Mission of GHPi

The Global Health Policy Institute (GHPi) is dedicated to the interdisciplinary study of important national, regional and global public health issues. The Institute focuses on core areas of research, capacity building, and policy advocacy by strategically partnering with other institutions, educational programs and individuals. The goal of GHPi is to address important and underserved issues in global and domestic health, engage a broad array of stakeholders in problem solving and consensus building, and lead in the development of evidence-based policymaking through research, instruction, and advocacy

Interdisciplinary

We believe that the only way to effectively tackle complex global health problems is through an interdisciplinary lens that embraces multiple areas of study, different stakeholders, and utilizes new and innovative cross-cutting methodologies

Research

Research and the evidence it generates should be at the core of global policymaking. To this aim, GHPi is dedicated to addressing underserved and important topics through innovative research and policy, law and governance inquiry

Education

To ensure evidence-based policymaking and advocacy, more global health practitioners with training in global health policy are necessary. GHPi fills this need by offering a variety of training and education options in the field

Announcements & Social

See below updates on our most recent publications, follow our Twitter feed on global health developments, and visit our Facebook for more updates on GHPi

Recent Publications

Tringale K, Marshall D, Mackey TK, Connor M, Murphy J, Hattangadi-Gluth J. Types and Distribution of Payments from Industry to Physicians in 2015. JAMA. 2017;317(17):1774-1784.

Mackey TK, Nayyar G.
A Review of Existing and Emerging Digital Technology to Combat the Global Fake Medicines Trade. Expert Opinion Drug Safety. 2017; advanced online publication

Cuomo RE, Mackey TK.
The Availability of Essential Cancer Medications: An Analysis of National Formularies. J Cancer Policy. 2017; 12:49-54.

Mackey TK, Liang BA.
In Reply - EHR and Drugs Prescribed for Off-label Indications. Mayo Clin Proc. 2017; 92(4):684-685.


Twitter Feed
Facebook Posts

Connect with us

Connect with us via social media to learn more about GHPi and receive updates!

© 2017 Global Health Policy Institute Contact Us